LETTER LETTER

Reply to Leithner et al.: Focus on phopshoenolpyruvate carboxykinase (PEPCK): A target of the p53-SIRT6-FoxO1 axis

Cancer metabolism has drawn widespread attention has been paid to PCK2 because it in-depth discussion and further study. The attention since the unique metabolic proper- has proved to be less enzymatically active discrepancy between normal and tumor ties of cells were characterized. We than PCK1, nevertheless, based on previous cells in PEPCK may provide a window found that p53, a potent tumor suppressor, studies of PCK2, we may make a bold spec- to understand cancer metabolism and the down-regulates the expression of phopshoe- ulation that PCK2 might be responsible for Warburg effect. nolpyruvate carboxykinase (PEPCK, PCK1) basal level and PCK1 for in coordination with histone deacetylase and nutrient stimulation, with Zhiming Li a and Wei-Guo Zhua,b,1 sirtuin 6 (SIRT6) to inhibit tumor cell more flexible regulation. Given the facts that aKey Laboratory of and gluconeogenesis (1). Because p53 is malfunc- cancer cells have faster metabolism rates and Translational Research (Ministry of Education), tioning in numerous types of cancer, the PCK1 is absent or expressed in low levels in Department of Biochemistry and Molecular p53-SIRT6-forkhead box protein O1 (FoxO1) manyotherorgans,theseeminglymorefun- Biology, Peking University Health Science axis may shed light on the “Warburg effect,” damental PCK2 may be motivated in tumor Center, Beijing 100191, China Beijing 100191, a phenomenon in cancer metabolism that cells under starvation. In addition, b has harassed scientists for decades. PCK1 is the general expression of PCK2 in most China; and Center for Life Sciences, Peking- mainly expressed in and , with an organs other than liver, such as islets, and its Tsinghua University, Beijing 100871, China increasing expression and maturation after mitochondrial location, may endow it with birth. PCK1 is localized in the and other functions in metabolism besides gluco- 1 Zhang P, et al. (2014) Tumor suppressor p53 cooperates with functions as the rate-limiting enzyme respon- neogenesis. For example, PCK2 is found to be SIRT6 to regulate gluconeogenesis by promoting FoxO1 nuclear sible for gluconeogenesis. Gluconeogenesis associated with glucose-stimulated se- exclusion. Proc Natl Acad Sci USA 111(29):10684–10689. has been mostly ascribed to PCK1 conven- cretion (5). It is possible that PCK2 may play 2 Beale EG, Hammer RE, Antoine B, Forest C (2004) Disregulated glyceroneogenesis: PCK1 as a candidate diabetes and obesity . tionally (2). Considering the unique expres- important roles in other metabolic processes Trends Endocrinol Metab 15(3):129–135, and erratum (2004) 15(5):192. sion of PCK1 in liver, which is the most in tumor cells with a different mechanism 3 Leithner K, Hrzenjak A, Olschewski H (2014) Gluconeogenesis in important organ in gluconeogenesis and cancer: Door wide open. Proc Natl Acad Sci USA, 10.1073/ from normal cells to influence cell growth pnas.1415680111. blood glucose maintenance, we may conclude and death. To test these two hypotheses, 4 Leithner K, et al. (2014) PCK2 activation mediates an adaptive that the p53-SIRT6-FoxO1 axis on PCK1 is it is necessary to examine the effect of the response to glucose depletion in . Oncogene, 10.1038/onc.2014.47. critical in gluconeogenic regulation in both p53-SIRT6-FoxO1 axis on PCK2 under both 5 Stark R, et al. (2009) Phosphoenolpyruvate cycling via normal and tumor cells. However, a recent quiescent and stress conditions in normal mitochondrial phosphoenolpyruvate carboxykinase links anaplerosis letter and study by Leithner et al. suggest or tumor cells. It is also critical to compare and mitochondrial GTP with insulin secretion. J Biol Chem 284(39): – that the mitochondrial isoform of PEPCK PCK1 and PCK2 in other models concerning 26578 26590. (PEPCK-M, PCK2) may be another key reg- cancer metabolism. Whether PCK1 or PCK2 ulator of metabolism and survival in cancer is more important in regulating gluconeo- Author contributions: Z.L. and W.-G.Z. wrote the paper.

cells(3,4).PCK2,insteadofPCK1,responds genesis may be context dependent, based The authors declare no conflict of interest. to glucose limitation in tumor cells and on the cellular background and nutrient 1To whom correspondence should be addressed. Email: involves tumor cell death (4). Although less supplies. Either way, this topic deserves [email protected].

www.pnas.org/cgi/doi/10.1073/pnas.1416664111 PNAS Early Edition | 1of1 Downloaded by guest on October 1, 2021